SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports ...
On Sunday the Democratic Republic of the Congo (DRC) reached a significant milestone in its fight against the Ebola outbreak, as the last patient was discharged.
It’s not an exaggeration to say that hope is in short supply these days in global health. The steep cuts to lifesaving global ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
The Administration for Strategic Preparedness and Response, part of HHS, has allocated $37.5 million to award dozens of hospitals grants of up to ...
Headquartered in Salt Lake City, Seek Labs is a proud member of BioHive, Utah's collaborative life sciences ecosystem. Together with our partners, we're building faster, smarter solutions for the ...
The countdown to declare the end of an Ebola outbreak in the Democratic Republic of Congo (DRC) has begun after the last ...
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...
Island Pharma aims to turn Galidesivir, its antiviral ace against Marburg, into reality – with the FDA’s November call to ...
A major milestone in the Democratic Republic of the Congo’s fight against Ebola. The last patient being treated since an ...
Barring new cases, the patient’s recovery kicks off a 42-day countdown to declaring the country’s 16th outbreak over.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback